Company / Capital Expenditures
Orthofix Medical Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$62.0M
FY2025
5-year range
$15.5M / $62.0M
FY2021-FY2025
Trend
+167.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has increased for 3 consecutive years, from $15M in FY2022 to $62M in FY2025.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of +35.5%.
Improved from $18M to $62M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +58.8%
- 5-Year CAGR
- +35.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Orthofix Medical Inc.'s capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +35.5%, indicating consistent growth.
- In FY2025, capital expenditures increased 167.9% year-over-year.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.0M | +167.9% |
| FY2024 | $23.2M | +30.2% |
| FY2023 | $17.8M | +14.9% |
| FY2022 | $15.5M | -18.5% |
| FY2021 | $19.0M | +39.8% |
| FY2020 | $13.6M | -7.3% |
| FY2019 | $14.7M | -10.8% |
| FY2018 | $16.4M | -39.6% |
| FY2017 | $27.2M | +50.5% |
| FY2016 | $18.1M | -27.1% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026